- Home
- BGM vs TBBK Comparison
BGM vs TBBK Comparison
Compare BGM & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- TBBK
- Stock Information
- Founded
- BGM 2019
- TBBK 1999
- Country
- BGM China
- TBBK United States
- Employees
- BGM 323
- TBBK N/A
- Industry
- BGM
- TBBK Major Banks
- Sector
- BGM
- TBBK Finance
- Exchange
- BGM NYSE
- TBBK Nasdaq
- Market Cap
- BGM 2.5B
- TBBK 2.4B
- IPO Year
- BGM 2021
- TBBK 2004
- Fundamental
- Price
- BGM $13.30
- TBBK $51.07
- Analyst Decision
- BGM
- TBBK Buy
- Analyst Count
- BGM 0
- TBBK 3
- Target Price
- BGM N/A
- TBBK $65.33
- AVG Volume (30 Days)
- BGM 78.7K
- TBBK 454.4K
- Earning Date
- BGM 08-13-2025
- TBBK 07-24-2025
- Dividend Yield
- BGM N/A
- TBBK N/A
- EPS Growth
- BGM N/A
- TBBK 20.50
- EPS
- BGM N/A
- TBBK 4.42
- Revenue
- BGM $25,097,951.00
- TBBK $502,282,000.00
- Revenue This Year
- BGM N/A
- TBBK N/A
- Revenue Next Year
- BGM N/A
- TBBK $6.71
- P/E Ratio
- BGM N/A
- TBBK $11.48
- Revenue Growth
- BGM N/A
- TBBK 10.02
- 52 Week Low
- BGM $5.26
- TBBK $33.77
- 52 Week High
- BGM $17.17
- TBBK $65.84
- Technical
- Relative Strength Index (RSI)
- BGM 50.76
- TBBK 48.64
- Support Level
- BGM $12.55
- TBBK $49.66
- Resistance Level
- BGM $17.17
- TBBK $51.43
- Average True Range (ATR)
- BGM 1.42
- TBBK 1.43
- MACD
- BGM -0.19
- TBBK -0.21
- Stochastic Oscillator
- BGM 32.01
- TBBK 36.77
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.